Faculté de Pharmacie, Institut Galien, Université Paris-Sud, 5 rue J.B. Clément, Châtenay-Malabry, F-92296, France.
Adv Exp Med Biol. 2014;811:183-206. doi: 10.1007/978-94-017-8739-0_10.
Advances in preparation technologies for nanomedicines have provided novel formulations for pulmonary drug delivery. Application of drugs via the lungs can be considered as one of the most attractive implementations of nanoparticles for therapeutic use due to the unique anatomy and physiology of the lungs. The colloidal nature of nanoparticles provides important advantages to the formulation of drugs, which are normally difficult to administer due to poor stability or uptake, partly because nanoparticles protect the drug from the physiological milieu, facilitate transport across biological barriers and can offer controlled drug release. There are numerous methods for producing therapeutic nanoparticles, each with their own advantages and suitable application. Liquid atomization techniques such as spray drying can produce nanoparticle formulations in a dry powder form suitable for pulmonary administration in a direct one-step process. This chapter describes the different state-of-the-art techniques used to prepare drug nanoparticles (with special emphasize on spray drying techniques) and the strategies for administering such unique formulations to the pulmonary environment.
纳米药物制剂技术的进步为肺部药物输送提供了新的制剂。由于肺部的独特解剖结构和生理学特性,通过肺部应用药物可以被认为是纳米颗粒治疗用途的最具吸引力的应用之一。纳米颗粒的胶体性质为药物制剂提供了重要的优势,由于稳定性或摄取性差,通常难以管理这些药物,部分原因是纳米颗粒可以保护药物免受生理环境的影响,促进穿过生物屏障的运输,并可以提供控制药物释放。有许多生产治疗性纳米颗粒的方法,每种方法都有其自身的优势和适用范围。液体雾化技术,如喷雾干燥,可以在直接一步法中以干粉形式生产适合肺部给药的纳米颗粒制剂。本章介绍了用于制备药物纳米颗粒的不同最先进技术(特别强调喷雾干燥技术)以及将这些独特制剂施用于肺部环境的策略。